Localization of 20-kD homologous restriction factor (HRF20) in diseased human glomeruli. An immunofluorescence study.
The 20-kD homologous restriction factor (HRF20), which is identical to CD59, is a membrane-associated protein which inhibits the reaction of C9 to form membrane attack complex (MAC) of homologous complements. In various human glomerular diseases deposition of complement components is frequently seen and MAC is reported to associate with immune deposits. Using a specific monoclonal antibody, 1F5, against HRF20, we attempted to study the localization of HRF20 in human glomerulonephritides and to compare the localization of HRF20 with those of immune deposits and MAC. The frozen sections of kidney specimens were fixed in acetone at room temperature before staining. In normal kidneys and kidney specimens from the patients with minimal change nephrotic syndrome, membranous nephropathy, and IgA nephropathy, HRF20 was strongly localized in the peritubular capillaries and along Bowman's capsules. A weaker but well-defined staining was obtained in the mesangial area and faint staining was seen along the glomerular capillary walls. In contrast, glomerular capillary walls were rather strongly stained in the cases with diffuse lupus nephritis which had subendothelial dense deposits. These data suggest that HRF20 (CD59) is present in the human glomeruli and its expression is enhanced under certain conditions such as lupus nephritis.
Tamai
H
H
Third Department of Internal Medicine, Nagoya University School of Medicine, Japan.
Matsuo
S
S
Fukatsu
A
A
Nishikawa
K
K
Sakamoto
N
N
Yoshioka
K
K
Okada
N
N
Okada
H
H
D000943:Antigens, Differentiation / Q000096:biosynthesis*; D018957:CD59 Antigens; D015922:Complement C1q / Q000032:analysis; D003176:Complement C3 / Q000032:analysis; D003181:Complement C4 / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D005455:Fluorescent Antibody Technique; D005922:Glomerulonephritis, IGA / Q000378:metabolism; D015433:Glomerulonephritis, Membranous / Q000378:metabolism; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007674:Kidney Diseases / Q000378:metabolism*; D007678:Kidney Glomerulus / Q000378:metabolism*; D008181:Lupus Nephritis / Q000378:metabolism; D008562:Membrane Glycoproteins / Q000096:biosynthesis*; D009402:Nephrosis, Lipoid / Q000378:metabolism
D000943:Antigens, Differentiation; D018957:CD59 Antigens; D003176:Complement C3; D003181:Complement C4; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D008562:Membrane Glycoproteins; D015922:Complement C1q; D005340:Fibrinogen